Navigation Links
IOS Press congratulates IPCC with Nobel Peace Prize
Date:12/10/2007

Amsterdam, 10 December 2007 The Norwegian Nobel Committee has awarded the Intergovernmental Panel on Climate Change (IPCC), represented by Dr. Rajendra K. Pachauri, and (former US Vice-President) Al Gore with the Nobel Peace Prize for 2007 for their efforts to build up and disseminate greater knowledge about man-made climate change, and to lay the foundations for the measures that are needed to counteract such change. Today, 10 December, the laureates will receive the Nobel Peace Prize at the Oslo City Hall in Norway.

Dr. Rajendra K. Pachauri, Chairman of the IPCC and Director-General of The Energy and Resources Institute (TERI) is also Editor-in-Chief of the journal Recourses, Energy and Development. IOS Press is responsible for the distribution and marketing outside India of this journal and several other TERI publications. We are very proud to work with Dr. Pachauri and hereby extend our warmest congratulations.

Through the scientific reports it has issued over the past two decades, the IPCC has created an ever-broader informed consensus about the connection between human activities and global warming. Thousands of scientists and officials from over one hundred countries have collaborated to achieve greater certainty as to the scale of the warming. Whereas in the 1980s global warming seemed to be merely an interesting hypothesis, the 1990s produced firmer evidence in its support. In the last few years, the connections have become even clearer and the consequences still more apparent.


'/>"/>

Contact: Susan Hendriks
s.hendriks@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Page: 1

Related biology news :

1. High blood pressure, low energy -- a recipe for heart failure
2. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
3. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
4. Bits of junk RNA aid master tumor-suppressor gene
5. American Chemical Societys Weekly Press Pac
6. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
7. New CPR promises better results by compressing abdomen, not Chest
8. American Chemical Societys Weekly PressPac -- Sept. 12, 2007
9. Women more depressed and men more impulsive with reduced serotonin functioning
10. American Chemical Societys Weekly PressPac -- Sept. 19, 2007
11. Studies: Children obese due to a host of unhealthy pressures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2016)...  xG Technology, Inc. ("xG" or the "Company") (Nasdaq: ... for use in challenging operating environments, announced its results ... will hold a conference call to discuss these results ... (details below). Key Recent Accomplishments ... agreement to acquire Vislink Communication Systems. The purchase is ...
(Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... finalists in the World Technology Awards. uBiome is one of just six company ... all categories. , In addition to uBiome, companies nominated as finalists in this ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. (OTCQB: ... focused on developing and commercializing products to treat rare ... today that it will be hosting an Investor Webcast ... on the origins of innate defense regulators (IDRs) as ... of oral mucositis and the recently announced and published ...
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... I/II dose escalation and expansion clinical trial for its lead drug candidate, AC0010, ... purpose of the trial was to determine the safety, antitumor activity, and recommended ...
Breaking Biology Technology: